NewsMV
$PDSB is in focus after PDS Biotechnology Corporation, incorporated in Delaware and listed on the Nasdaq Capital Market, filed an 8-K disclosing a First Amendment to its $6 million Promissory Note with YA II PN, Ltd., dated August 31, 2026.
The revised terms give YA II PN a first claim on essentially every equity dollar the Princeton, New Jersey company raises.
The amendment takes effect only after PDS Biotechnology pays the installment due September 14, 2026 in full. The original note, issued June 15, 2026, carried a principal of $6,000,000.
Under the First Amendment, the company must now deliver weekly remittance notices to YA II PN detailing net proceeds received from its at-the-market offering program during the prior week, with the applicable portion of those proceeds due within one business day of each notice.
Keep reading